Federal Register / Vol. 65, No. 191 / Monday, October 2, 2000 / Notices 58779

other related issues; facilitating increased

DHHS and agency awareness of CFS research

and educational needs; developing

complementary research programs that

minimize overlap; identifying opportunities

for collaborative and/or coordinated efforts in

research and education; and developing

informed responses to constituency groups

regarding DHHS and SSA efforts and

progress.

Matters To Be Discussed: The meeting will

include a discussion of the CFS State of the

Science Conference held October 23–24,

2000; progress report from the Name Change

Working Group; update on current Federal

activities; and identification of areas for

future focus for the CFSCC. Public comments

will be received at the meeting on two topics

of interest to the Committee: (1) Lack of

access to social services and (2) insensitive

medical care. Persons wishing to make oral

comments on these topics either in person or

via video should notify the contact person

listed below no later than COB on October

17, 2000. Five minutes will be allotted for

each statement; both printed and electronic

copies are requested for the record.

Contact Person for More Information:

Janice C. Ramsden, Executive Secretary,

CFSCC, Office of the Principal Deputy

Director, NIH, Building 1, Room 333, 1

Center Drive, MSC 0159, Bethesda, Maryland

20892–0159, e-mail jr52h@nih.gov or

telephone 301–496–0959.

Dated: September 22, 2000.

LaVerne Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25163 Filed 9–29–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such patentable material, and

personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel.

Dates: October 30, 2000.

Time: 8:30 AM to 4:00 PM.

Agenda: To review and evaluate contract

proposals.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Edward W. Schroder, PHD,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2156, 6700–B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301–496–2550.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: September 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25156 Filed 9–29–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given on the following

meeting.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Microbiology and

Infectious Diseases Research Committee.

Dates: October 4–5, 2000.

Open: October 4, 2000, 9:00 AM to 10:00

AM.

Agenda: Reports from various Institute

staff.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

DC 20037.

Closed: October 4, 2000, 9:00 AM to

adjournment on October 5, 2000.

Agenda: To review and evaluate grant

applications.

Place: One Washington Circle Hotel,

Conference Center, One Washington Circle,

DC 20037.

Contact Person: Gary S. Madonna, PhD,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2217, 6700–B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301–496–2550.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: September 21, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25157 Filed 9–29–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Deafness and Other Communications

Disorders Special Emphasis Panel.

Dates: November 14–15, 2000.

Time: 8 AM to 12 PM.

Agenda: To review and evaluate grant

applications.

Place: The Virginian Suites, 1500

Arlington Blvd., Arlington, VA 22209.

Contact Person: Stanley C. Oaks, Jr., PhD,

Scientific Review Branch, Division of

Extramural Research, Executive Plaza South,

Room 400C, 6120 Executive Blvd., Bethesda,

MD 20892–7180, 301–496–8683.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research